Blog Posts
Myriam Chalabi
Photo of Myriam Chalabi taken from avl.nl

Myriam Chalabi presented the first results from the NEOASIS study at AACR25 – Agenus

Agenus shared a post on LinkedIn:

“Today at AACR25, Dr. Myriam Chalabi presented the first results from the NEOASIS study, evaluating neoadjuvant botensilimab/balstilimab in early-stage MSS and MSI-H cancers, including colorectal and breast cancers.

Learn more.”

Myriam Chalabi

More posts from AACR25.

AACR25 Agenus Breast Cancer cancer colorecta cancer Myriam Chalabi OncoDaily Oncology